Motherwell-based biotech company TC BioPharm (TCB) is to begin clinical trials of an experimental therapy designed to kill Covid-19 infected cells. TCB previously used gamma-delta T cells (GDTs) donated from healthy volunteers to treat cancer patients and believes they could boost the immune system of those being treated for Covid. It has now gained regulatory approval.